Open original FDA record ↗Recall record
- FDA identifier
- Z-2232-2014
- Company in FDA record
- BioMerieux SA
- FDA classification date
- Aug 14, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Customer complaints about not repeatable results below the detection limit (<45 ng/mL). Therefore false negatives are being reported for results around the medical decision point of 500 ng/mL that initially tested at <45 ng/mL.
Source facts
- Action
- A recall letter was issued on 4/17/2013 to US customers via FED Ex mailing. The letter included a fax back acknowledgment form. A recall notice was also sent via email to bioMerieux Subsidiaries and international distributors on 4/11/2013.
- Initiated
- 2013-04-17
- Root cause
- Under Investigation by firm
- Terminated
- 2014-10-08
- Distribution
- AL, AR, CA, CO, CT, DE, FL, GA, ID, IL, IN, IA, KS, KY, LA, ME, MA, MI, MN, MO, MT, NE, NH, NJ, NY, NC, OH, OK, OR, PA, RI, SC, TN, TX, VT, VA, WA, WV, WI, WY
- Recall number
- Z-2232-2014
- Recall status
- Terminated
- CDRH record ID
- 128596
- FDA classified
- 2014-08-14
- Recall event number
- 68747